Results 41 to 50 of about 9,360,292 (409)
Approach to the management of rheumatic arthritis
South African Journal of Physiotherapy, 1967 No abstract available.
D. A. Gordon, M. A. Ogryzlo
doaj +1 more source
Blood Pressure, 2023 Purpose Hypertension is a major cardiovascular (CV) risk factor in ankylosing spondylitis (AS) patients. Less is known about the prevalence of CV organ damage in relation to hypertension status in AS patients.
Gyda Ullensvang +9 more
doaj +1 more source
Data quality predicts care quality: findings from a national clinical audit
Arthritis Research & Therapy, 2020 Background Missing clinical outcome data are a common occurrence in longitudinal studies. Data quality in clinical audit is a particular cause for concern.
Mark Yates +6 more
doaj +1 more source
Histopathology of the gut in rheumatic diseases [PDF]
, 2018 The gastrointestinal tract regulates the trafficking of macromolecules between the environment and the host through an epithelial barrier mechanism and is an important part of the immune system controlling the equilibrium between tolerance and immunity ...
Ciccia F. +4 more
core +1 more source
Medical Journal of Australia, 2020 Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) cause significant morbidity and premature mortality among Australian Aboriginal and Torres Strait Islander peoples.
A. Ralph, S. Noonan, V. Wade, B. Currie
semanticscholar +1 more source
Genetics of rheumatic disease [PDF]
Arthritis Research & Therapy, 2009 Many of the chronic inflammatory and degenerative disorders that present to clinical rheumatologists have a complex genetic aetiology. Over the past decade a dramatic improvement in technology and methodology has accelerated the pace of gene discovery in complex disorders in an exponential fashion.
Alexander J. Clarke, Timothy J. Vyse
openaire +3 more sources
Vitamin D supplementation in the pediatric rheumatology clinic. [PDF]
, 2011 Vitamin D is capturing the attention of healthy and chronically ill populations for its potential skeletal and nonskeletal benefits. New information suggesting a role in immune modulation has led to a surge of interest among rheumatologists. Although the
Burnham, Jon M, von Scheven, Emily
core +3 more sources
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus. [PDF]
, 2020 ObjectiveTo evaluate the frequency of cell-bound complement activation products (CB-CAPs) as a marker of complement activation in patients with suspected systemic lupus erythematosus (SLE) and the usefulness of this biomarker as a predictor of the ...
Alexander, Roberta Vezza +12 more
core +2 more sources
Osteoporosis in Rheumatic Diseases
International Journal of Molecular Sciences, 2019 Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patients affected by rheumatic diseases with special focus ...
Adami, Giovanni +7 more
openaire +4 more sources
RMD Open, 2019 Objective To assess whether the polymyalgia rheumatica (PMR)-like syndrome reported as an immune related adverse event (irAE) from checkpoint inhibitor therapy is consistent with the 2012 European League Against Rheumatism (EULAR)/American College of ...
Marie Kostine +5 more
doaj +1 more source